Tangential Flow Filtration (TFF) is a critical unit operation in the downstream processing of biopharmaceuticals, primarily used for the concentration and diafiltration (buffer exchange) of protein solutions. While TFF is relatively straightforward at the bench scale, scaling it up to pilot or commercial manufacturing presents a unique set of hydrodynamic and operational challenges.
Shear Stress and Protein Stability
One of the foundational principles of scaling up TFF is maintaining a constant shear rate. In hollow fiber or flat sheet cassettes, the feed flow rate must be scaled linearly with the membrane area to keep the shear stress on the protein consistent. Proteins are sensitive molecules; excessive shear generated by pumps or narrow flow paths can lead to unfolding, aggregation, and ultimate loss of product yield.
Managing Concentration Polarization
Another major consideration is mass transfer and concentration polarization. As the protein concentration increases at the membrane wall, it forms a gel layer that significantly reduces the permeate flux. At commercial scales, optimizing the transmembrane pressure (TMP) and crossflow velocity is essential to balance a high flux rate without causing irreversible membrane fouling. Exceeding the critical TMP will not increase flux, but rather compress the gel layer, making the process highly inefficient.
Hardware and System Hold-Up
Finally, hardware limitations must be factored in. Piping diameters, pump capacities, and hold-up volumes in large-scale skids differ drastically from benchtop systems. A common scale-up failure occurs when the minimum recirculation volume of the manufacturing skid is larger than the final required retentate volume, making it impossible to reach the target concentration factor. Careful modeling of the entire flow path is critical for a successful tech transfer.
The Importance of TMP and Flux Control
Transmembrane pressure (TMP) and permeate flux are the critical control parameters in TFF. A common scale-up failure mode occurs when TMP profiles are not identical across scales, leading to premature membrane fouling or product polarization at the membrane surface. By meticulously modeling the hydrodynamics and utilizing modern single-pass TFF (SP-TFF) configurations, engineers can mitigate these risks and ensure a smooth transition from R&D to commercial manufacturing.
References
- Raghunath, B., et al. (2012). Best Practices for Optimization and Scale-Up of Microfiltration TFF Processes. BioProcess Journal, 11(1): 30-40. doi:10.12665/J111.Raghunath
- Guan, Y., et al. (2016). A scale-down cross-flow filtration technology for biopharmaceuticals and the associated theory. Journal of Biotechnology. doi:10.1016/j.jbiotec.2016.01.002